cholangioscopy (Frimberger)
Devicecholangioscopy with Frimberger duodenoscope system by the company of Karl Storz GmbH
NCT Number: NCT01683240
Karl Storz GmbH (Gesellschaft mit beschränkter Haftung) company developed a cholangioscopic device, which is designed to give a better flexibility to the cholangioscopy tip in order to enable optimal diagnostic and therapeutic precondition. Other than the conventional mother-baby technique, the insertion of the cholangioscope (baby part) is done by a port at the side of a specially developed duodenoscope (mother part) which is prepositioned distally to the control unit, near to the patient's mouth. Better manoeuverability of the device tip will lead to both a better accuracy in taking biopsies as well as a better flexibility in lithotripsy manoeuvres. This study is designed to test the efficiency of the device in relation to this assumption.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Charité Universitätsmedizin, Virchow Klinikum, Berlin, Germany
Cholangioscopy is a subsidiary treatment in endoscopic retrograde cholangiopancreaticography (ERCP), used for special issues. In the context of ERCP, a long,thin shaped device is introduced through the working channel of a duodenoscope and then through the papilla into the biliary duct.
Inspection of the biliary duct can be used for tumor biopsies as well as for gall stone lithotripsy by laser or electrohydraulic technique.
Manoeuverability of cholangioscopes is limited by the length of the scope, even more, since most of the device body is stuck in the working channel.
The newly designed cholangioscope by the company of Karl Storz GmbH is introduced through a shortened working channel. Introduction of the cholangioscope is done by an innovative side port for the cholangioscope at 70 cm from the insertion tube's distal end. This leads to a better flexibility of the device tip. Better manoeuverability of the device tip will lead to both a better accuracy in taking biopsies as well as a better flexibility in lithotripsy manoeuvres.
This study is designed to test the efficiency of the device in relation to this assumption.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
cholangioscopy with Frimberger duodenoscope system by the company of Karl Storz GmbH
Time frame: Patients will be monitored during stay in hospital, average stay is 1 day
Time frame: while examination and 24 hrs past examination
Number of complications during examination and during monitoring over 24 hours post procedure
Time frame: procedure, average procedure time 1 hour
Time of procedure and success of stone extraction in %
Time frame: procedure, average procedure time is 1 hour
Number of biopsies taken. Evaluation of quality of biopsies by pathologists (pathological department of University Hospital Hamburg Eppendorf).
Minimum number of bioptic manoeuvres: 3 Comparison with brush cytology (3 brush manoeuvres with 12 smear preparations) by reference cytologist (Dr. Topalidis, Hannover)
Universitätsklinikum Hamburg-Eppendorf
Other
Acronym: SAC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04968873
Bile Duct Diseases, Biliary Tract Diseases
View Trial DetailsNCT06197984
Bile Duct Diseases, Biliary Tract Diseases
Timișoara, Romania
View Trial DetailsNCT06265311
Bile Duct Diseases, Biliary Tract Diseases
Shanghai, China
View Trial DetailsNCT07417020
Bile Duct Diseases, Bile Duct Disorder
Lahore, Punjab Province, Pakistan
View Trial Details